Loading…
Simulations Plus, Inc. is projected to decline to $15.47 by 2027, a -1% move from its current price of $15.55. SLP is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $15.10 | $15.55 | $16.02 | +0.03% |
| May 30 | $14.92 | $15.56 | $16.22 | +0.06% |
| May 31 | $14.79 | $15.56 | $16.38 | +0.09% |
| Jun 1 | $14.67 | $15.57 | $16.52 | +0.12% |
| Jun 2 | $14.58 | $15.57 | $16.64 | +0.15% |
| Jun 3 | $14.49 | $15.58 | $16.75 | +0.18% |
| Jun 4 | $14.41 | $15.58 | $16.85 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.41 | $15.58 | $16.85 | +0.21% |
| Week 2 | $13.98 | $15.62 | $17.44 | +0.43% |
| Week 3 | $13.67 | $15.65 | $17.92 | +0.64% |
| Week 4 | $13.41 | $15.68 | $18.34 | +0.85% |
| Week 5 | $13.19 | $15.72 | $18.72 | +1.07% |
| Week 6 | $13.00 | $15.75 | $19.08 | +1.29% |
| Week 7 | $12.83 | $15.78 | $19.41 | +1.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Simulations Plus, Inc. is a Healthcare company that develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments.
The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales products. In addition, the company offers Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions.
Further, it provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, the company offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies.
Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Research Triangle Park, North Carolina.
Simulations Plus, Inc. (SLP) is a healthcare stock with a current price of $15.37. It has a market capitalization of $310.56M and is ranked 3491 by market size. The stock operates within the Healthcare sector.
The forecast indicates upside potential over the coming years, with the average price rising from $15.37 in 2026 to higher levels in 2030 and beyond, including a 2030 average of $18.16 and a 2050 average of $68.53. The maximum forecast values extend to $133.51 by 2050, suggesting substantial longer-term upside, though near-term volatility remains part of the picture.
A major floor 26.9% below — a decisive break under it would weaken the trend.
The nearest floor, 14.2% below — buyers have tended to step in here.
The nearest ceiling, 7.3% above — a clean break opens room to run.
A major ceiling 34.0% above — clearing it would confirm fresh momentum.
Key SLP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SLP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $15.16 | Buy | $15.14 | Buy |
| MA 10 | $14.39 | Buy | $14.86 | Buy |
| MA 20 | $14.76 | Buy | $14.65 | Buy |
| MA 50 | $13.70 | Buy | $14.28 | Buy |
| MA 100 | $14.56 | Buy | $14.68 | Buy |
| MA 200 | $15.50 | Buy | $16.56 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.04 | Neutral |
| Stoch RSI (14) | 58.51 | Neutral |
| CCI (20) | 65.03 | Neutral |
| Williams %R (14) | -33.83 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | -6.77 | Sell |
| Bollinger %B (20,2) | 0.71 | Neutral |
| Stochastic %K (14) | 66.17 | Neutral |
| TRIX (15) | 0.26 | Buy |
| Awesome (5,34) | 0.61 | Buy |
| Ultimate (7,14,28) | 76.54 | Sell |
| Momentum (10) | 1.59 | Buy |
| Aroon Osc (25) | -20.00 | Sell |
| Hull MA (9) | 15.78 | Sell |
| ADX (14) | 19.25 | Neutral |
| ATR (14) | 0.40 | Info |
The 30-day technical picture is Neutral, with the RSI14 at 60. The near-term trend is influenced by the SMA50 at $13.57 and the SMA200 at $15.49. Support is seen at $12.95 and resistance at $16.68, framing a 30-day price range from $12.51 to $18.88. With a neutral sentiment, the near-term path could drift within these levels as traders assess catalysts.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.36 | $15.55 | $19.84 | 0% | Neutral | |
| $12.17 | $15.47 | $20.89 | -1% | Neutral | |
| $12.03 | $15.75 | $22.09 | +1% | Neutral | |
| $12.80 | $17.18 | $24.84 | +10% | Neutral | |
| $13.40 | $18.39 | $27.27 | +18% | Neutral | |
| $15.61 | $21.86 | $33.15 | +41% | Bullish | |
| $17.14 | $24.47 | $37.85 | +57% | Bullish | |
| $15.78 | $22.92 | $36.11 | +47% | Bullish | |
| $15.96 | $23.59 | $37.79 | +52% | Bullish | |
| $16.26 | $24.43 | $39.74 | +57% | Bullish | |
| $22.73 | $36.77 | $63.82 | +136% | Bullish | |
| $37.79 | $69.59 | $132.73 | +348% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $11.36 | $15.55 | $18.25 | +0.00% |
| June 2026 | $13.13 | $15.45 | $18.63 | -0.66% |
| July 2026 | $13.47 | $15.99 | $19.56 | +3.50% |
| August 2026 | $13.68 | $16.36 | $20.24 | +2.32% |
| September 2026 | $13.25 | $15.93 | $19.89 | -2.60% |
| October 2026 | $12.94 | $15.65 | $19.70 | -1.75% |
| November 2026 | $13.04 | $15.85 | $20.09 | +1.22% |
| December 2026 | $12.73 | $15.54 | $19.84 | -1.92% |
Click any year to see its month-by-month SLP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, SLP is projected to trade between $11.36 and $19.84, averaging $15.55 — a potential gain of 0% from today's $15.55. Price action looks broadly range-bound.
Simulations Plus, Inc.'s 2027 outlook centres on $15.47, within a $12.17 to $20.89 range. That is -1% versus the projected 2026 average. That marks a -1% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, SLP could reach as high as $22.09, with a base case around $15.75 and support toward $12.03 — roughly +1% from $15.55. Price action looks broadly range-bound.
Expect SLP to range from $12.80 to $24.84 through 2029. The $17.18 average target implies a +10% move from current prices. That is up +9% on the projected 2028 average. A consolidation phase looks the most probable path here.
The SLP price prediction for 2030 points to an average of $18.39 (low $13.40, high $27.27) — a potential gain of +18% on today's $15.55. Price action looks broadly range-bound.
In 2031, SLP is projected to trade between $15.61 and $33.15, averaging $21.86 — a potential gain of +41% from today's $15.55. That is up +19% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Simulations Plus, Inc.'s 2032 outlook centres on $24.47, within a $17.14 to $37.85 range. That is up +12% on the projected 2031 average. That marks a +57% change versus current levels. Momentum favours further upside here.
By 2033, SLP could reach as high as $36.11, with a base case around $22.92 and support toward $15.78 — roughly +47% from $15.55. Buyers look set to stay in control over this stretch.
Expect SLP to range from $15.96 to $37.79 through 2034. The $23.59 average target implies a +52% move from current prices. That is up +3% on the projected 2033 average. Momentum favours further upside here.
The SLP price prediction for 2035 points to an average of $24.43 (low $16.26, high $39.74) — a potential gain of +57% on today's $15.55. Buyers look set to stay in control over this stretch.
In 2040, SLP is projected to trade between $22.73 and $63.82, averaging $36.77 — a potential gain of +136% from today's $15.55. That is up +51% on the projected 2035 average. Momentum favours further upside here.
Simulations Plus, Inc.'s 2050 outlook centres on $69.59, within a $37.79 to $132.73 range. That is up +89% on the projected 2040 average. That marks a +348% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in SLP today (≈ 64.308682 SLP) could be worth
$4,475.09
+$3,475.09 (+348%) by 2050 · US Dollar
Based on the average projected SLP price of $69.59 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SLPwould be worth at today's price.
$1,000 invested in SLP on May 27, 2025 (≈ 31.026994 SLP) would be worth
$482.47
-$517.53 (-51.8%) today · 0.48× · US Dollar
Based on a SLP entry price of $32.23 vs. today's $15.55.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $14.47 | $1,074.64 | +7.5% |
| 1 month ago | $14.61 | $1,064.34 | +6.4% |
| 3 months ago | $12.09 | $1,286.19 | +28.6% |
| 6 months ago | $17 | $914.71 | -8.5% |
| 1 year ago | $32.23 | $482.47 | -51.8% |
| All time (5.0y) ago | $52.47 | $296.36 | -70.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SLP forecast.
Our base-case forecast reaches $31.00 around 2040.
Implied market cap at $31.00: $626.37M
The multi-year forecast shows a gradual rise in average prices from 2026 through 2029, with 2026 avg $15.37, 2027 avg $15.26, 2028 avg $15.54, and 2029 avg $16.75. Corresponding ROI values are 0, -0.7, 1.1, and 9 respectively, with a NEUTRAL outlook in those years. By 2030, the average price is forecast at $18.16 with an ROI of 18.1 and a NEUTRAL sentiment.
In 2031 the average rises to $21.75, with an ROI of 41.5, followed by 2032 at $24.17 (ROI 57.3) and 2033 at $22.60 (ROI 47). The 2034 and 2035 forecasts are $23.24 and $23.93 with ROI of 51.2 and 55.7 respectively, continuing the bullish shift. Looking further out, 2040 is forecast at an average of $36.52 with an ROI of 137.6 and a BULLISH stance, while 2050 is forecast at an average of $68.53 with an ROI of 345.9 and a BULLISH stance.
The upside potential is underscored by the max forecast values: $27.26 in 2030, $64.54 in 2040, and $133.51 in 2050. These figures illustrate meaningful long-term upside but are not guarantees and carry inherent investment risk. Drivers of movement include market conditions and company-specific factors; risks include near-term volatility and variability around forecasted ranges.
In sum, the outlook points to substantial long-term upside, tempered by short-term uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $18.16 with a forecasted ROI of 18.1. The 2030 min and max are $13.09 and $27.26 respectively.
Forecasts show a bullish shift beginning in 2031, with 2031 avg $21.75 and 2032 avg $24.17, continuing through 2050 where the avg is $68.53 and the ROI reaches 345.9. However, near-term years such as 2027 show a negative or flat ROI in the data, so outcomes are not guaranteed.
Yes. The 2050 forecast max is $133.51, and the 2050 average is $68.53 with an ROI of 345.9, indicating potential for substantial upside by 2050.
The 30-day range is from $12.51 to $18.88.
Current price: $15.37. Market cap: $310.56M. The stock is ranked 3491.
Simulations Plus, Inc. Community Discussion
0Share your Simulations Plus, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.